Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
Endo Health Solutions (Nasdaq: ENDP) today announced that it has completed its annual goodwill and in-process research and development (IPR&D)...
Endo Health Solutions (Nasdaq: ENDP) today announced that the South African Competition Commission has completed its review and approved the merger...
Unique Generics Product Portfolio, Attractive Pipeline, Builds On Qualitest's Strength In Controlled Substances Transaction Expected To Be...
Endo Health Solutions (Nasdaq: ENDP) today confirmed that the United States District Court for the District of Delaware ruled that United States...
Endo Health Solutions (Nasdaq: ENDP) today announced that NuPathe Inc. (NASDAQ: PATH) has terminated its merger agreement with Endo. Endo has...
Altaris Capital Partners to acquire HealthTronics for a total consideration of up to $130 million including $85 Million in cash upfront HealthTronics ...
Endo Health Solutions (Nasdaq: ENDP) today announced that Rajiv De Silva, President and Chief Executive Officer, will present a corporate overview at ...
Endo Health Solutions (Nasdaq: ENDP) ("Endo") today announced that Endo Finance Co., its wholly-owned subsidiary ("Endo Finance"), intends to offer,...
Endo Health Solutions (Nasdaq: ENDP) ("Endo") today announced that Endo Finance Co., its wholly-owned subsidiary ("Endo Finance"), priced $700...
Endo Health Solutions (NASDAQ: ENDP) today announced that Arthur J. Higgins has been appointed to its Board of Directors, effective immediately. Endo ...
Endo Health Solutions (Nasdaq: ENDP) ("Endo") today announced that it has commenced consent solicitations with respect to proposed amendments to the...
Total quarterly revenues of $715 million, decreased by 5 percent versus prior year. Third quarter reported diluted (GAAP) EPS of $0.33; Third quarter ...
Accelerates Endo's transformation to leading global specialty healthcare company and creates platform for future growth Paladin Labs' proven Canadian ...
Endo Health Solutions (Nasdaq: ENDP) will announce its third quarter 2013 financial results before the open of the U.S. financial markets on November ...
Endo Health Solutions Inc. (Nasdaq: ENDP), a U.S. based specialty healthcare company, announced today that it had appointed Suketu "Suky" Upadhyay as ...
Endo Health Solutions (Nasdaq: ENDP) today announced that its wholly owned subsidiary, HealthTronics, Inc. has entered into a definitive agreement to ...
Total quarterly revenues of $767 million, decreased by 2 percent versus prior year. Second quarter reported diluted (GAAP) EPS of $0.30; Second...
Endo Health Solutions (Nasdaq: ENDP) today outlined the strategic, operational and organizational steps it is taking to refocus the Company and drive ...
Total quarterly revenues of $709 million, increased by 3 percent versus prior year. First quarter reported diluted (GAAP) EPS of $0.14. First quarter ...
Total quarterly revenues of $801 million, comparable to prior year. Fourth quarter reported diluted (GAAP) loss per share of $6.35 includes a $640...
Reaffirms 2012 Adjusted Diluted EPS to be at or Below Low End of Previous Range of $5.00-$5.10 Company expects asset impairment and other charges to...
Endo Health Solutions (Nasdaq: ENDP) today announced that Julie McHugh, chief operating officer, will present a corporate overview at the 2012 Annual ...
Endo Health Solutions (Nasdaq: ENDP) today announced that Alan Levin, chief financial officer, will present a corporate overview at the Jefferies...
Total quarterly revenues of $750 million, decreased 1 percent versus prior year Qualitest quarterly net sales increase by 12 percent versus prior...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.